References
- Kahane S, Gonen R, Sayada C, Elion J, Friedman MG. Description and partial characterization of a new Chlamydia-like microorganism. FEMS Microbiol Lett 1993; 109: 329–33
- Everett KD, Bush RM, Andersen AA. Amended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing 1 monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and 5 new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999; 49: 415–40
- Kahane S, Greenberg D, Newman N, Dvoskin B, Friedman MG. Domestic water supplies as a possible source of infection with Simkania. J Infect 2007; 54: 75–81
- Friedman MG, Galil A, Geenberg S, Kahane S. Seroprevalence of IgG antibodies to the Chlamydia-like microorganism ‘Simkania Z’ by ELISA. Epidemiol Infect 1999; 122: 117–23
- Johnsen S, Birkebaek N, Andersen PL, Emil C, Jensen J, Ostergaard L. Indirect immunofluorescence and real time PCR for detection of Simkania negevensis infection in Danish adults with persistent cough and in healthy controls. Scand J Infect Dis 2005; 37: 251–5
- Friedman M, Kahane S, Dvoskin B, Hartely J. Detection of Simkania negevensis by culture, PCR, and serology in respiratory tract infection in Cornwall, UK. J Clin Pathol 2006; 59: 331–3
- Yamaguchi T, Yamazaki T, Inoue M, Mashida C, Kawagoe K, Ogawa M, et al. Prevalence of antibodies against Simkania negevensis in a healthy Japanese population determined by the microimmunofluorescence test. FEMS Immunol Med Microbiol 2005; 43: 21–7
- Friedman MG, Dvoskin B, Kahane S. Infections with the Chlamydia-like microorganism Simkania negevensis, a possible emerging pathogen. Microbes Infect 2003; 5: 1013–21
- Korppi M, Paldanius M, Hyvärinen A, Nevalainen A. Simkania negevensis and newly diagnosed asthma: a case-control study in 1- to 6-y-old children. Respirology 2006; 11: 80–3
- Greenberg D, Banerji A, Friedman MG, Chiu CH, Kahane S. High rate of Simkania negevensis among Canadian Inuit infants hospitalized with lower respiratory tract infections. Scand J Infect Dis 2003; 35: 506–8
- Kahane S, Greenberg D, Friedman MG, Haikin H, Dagan R. High prevalence of ‘Simkania Z’, a novel Chlamydia-like bacterium, in infants with acute bronchiolitis. J Infect Dis 1998; 177: 1425–9
- Lieberman D, Kahane S, Lieberman D, Friedman MG. Pneumonia with serological evidence of acute infection with the Chlamydia-like microorganism ‘Z’. Am J Respir Crit Care Med 1997; 156: 578–82
- Don M, Fasoli L, Paldanius M, Vainionpää R, Kleemola M, Räty R, et al. Aetiology of community acquired pneumonia: serological result of a paediatric survey. Scand J Infect Dis 2005; 37: 806–12
- Don M, Valent F, Korppi M, Falleti E, De Candia A, Fasoli L, et al. Efficacy of serum procalcitonin in evaluating severity of community acquired pneumonia in childhood. Scand J Infect Dis 2007; 39: 129–37
- Don M, Paldanius M, Fasoli L, Canciani M, Korppi M. Simkania negevensis and pneumonia in children. Pediatr Infect Dis J 2006; 25: 470–1
- Kahane S, Kimmel N, Friedman MG. The growth cycle of Simkania negevensis. Microbiol 2002; 148: 735–42
- Korppi M, Paldanius M, Hyvarinen A, Nevalainen A, Husman T. Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1- to 6-y-old children. Respirology 2004; 9: 255–9
- Miyashita N, Obase Y, Fukuda M, Shoji H, Mouri K, Yagi S, et al. Evaluation of serological tests detecting Chlamydiophila pneumoniae-specific immunoglobulin M antibody. Intern Med 2006; 45: 1127–31
- Apfalter P, Reischl U, Hammerschlag MR. In-house nucleic acid amplification assays in research: how much quality control is needed before one can rely upon the results?. J Clin Microbiol 2005; 43: 5835–41
- Kumar S, Kohlhoff SA, Gelling M, Roblin PM, Kutlin A, Kahane S, et al. Infection with Simkania negevensis in Brooklyn, New York. Pediatr Infect Dis J 2005; 24: 989–92